SA
SPRY logo
ARS Pharmaceuticals, Inc.(SPRY)
Closing price · checked 4:22 PM ETAbout this dataData status
$3.36▼-0.33 (-8.94%)
After Hours:$3.36+0.00 (+0.00%)· 4:22 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.9 · elevated volatility

Overview →
Next report

Mar 8 2027in 109 days

EPS estimate

($0.32)

Revenue estimate

$30M

EPS beats

5 of last 12

Earnings SurpriseEPS, actual vs estimateLatest -18.0%

How far reported EPS beat (+) or missed (−) the analyst estimate that stood when each report landed.

2024: 0.0%2024: -8.3%2024: -11.1%2025: 1400.0%2025: 0.0%2025: -12.2%2025: -15.6%2026: 0.0%2026: -15.1%2026: -31.9%2026: -18.0%0.0%-11.1%0.0%-15.6%-15.1%-18.0%
May 9 2024Nov 5 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Nov 5 2026($0.30)($0.36)-18.0%$42M$38M-10.2%
Aug 13 2026($0.48)($0.63)-31.9%$31M$34M+7.5%
May 15 2026($0.53)($0.61)-15.1%$22M$23M+2.2%
Mar 9 2026($0.42)($0.42)+0.0%$26M$28M+9.7%
Nov 10 2025($0.45)($0.52)-15.6%$26M$33M+27.0%
Aug 13 2025($0.41)($0.46)-12.2%$28M$16M-43.2%
May 14 2025($0.35)($0.35)+0.0%$15M$8M-45.8%
Mar 20 2025($0.04)$0.52+1400.0%$13M$87M+574.4%
Nov 13 2024($0.18)($0.20)-11.1%$17M$2M-87.9%
Aug 6 2024($0.12)($0.13)-8.3%$1M$500000-50.0%
May 9 2024($0.11)($0.11)+0.0%———
Mar 21 2024($0.14)($0.07)+50.0%—$30000—

Earnings & Revenue Estimates

Q3 2026
Checking for summary...

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.